UniSuper Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.41M | Sell |
16,648
-189
| -1% | -$84.1K | 0.05% | 189 |
|
|
2025
Q1 | $8.16M | Buy |
16,837
+563
| +3% | +$273K | 0.06% | 171 |
|
|
2024
Q4 | $6.55M | Buy |
16,274
+4,017
| +33% | +$1.62M | 0.05% | 189 |
|
|
2024
Q3 | $5.7M | Buy |
12,257
+200
| +2% | +$93K | 0.04% | 211 |
|
|
2024
Q2 | $5.65M | Buy |
12,057
+6,225
| +107% | +$2.92M | 0.05% | 197 |
|
|
2024
Q1 | $2.44M | Buy |
5,832
+3,743
| +179% | +$1.56M | 0.02% | 225 |
|
|
2023
Q4 | $850K | Sell |
2,089
-1,839
| -47% | -$748K | 0.01% | 275 |
|
|
2023
Q3 | $1.37M | Sell |
3,928
-439
| -10% | -$153K | 0.02% | 242 |
|
|
2023
Q2 | $1.54M | Buy |
+4,367
| New | +$1.54M | 0.02% | 242 |
|